Humoral immune defect
|
group |
Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
29
|
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Vascular Hemostatic Disorders
|
group |
Hemic and Lymphatic Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
7
|
1
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Arteriopathic disease
|
group |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
101
|
14
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Infectious Lung Disorder
|
group |
Infections; Respiratory Tract Diseases
|
Disease or Syndrome
|
185
|
1
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Chronic Kidney Diseases
|
group |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
1074
|
306
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Infection - suppurative
|
group |
Pathological Conditions, Signs and Symptoms; Infections
|
Disease or Syndrome
|
20
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
MYELODYSPLASTIC SYNDROME
|
group |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1033
|
95
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Diverticular Diseases
|
group |
Digestive System Diseases
|
Disease or Syndrome
|
83
|
88
|
0.400 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Venous Thromboembolism
|
phenotype |
Cardiovascular Diseases
|
Disease or Syndrome
|
378
|
408
|
0.200 |
None |
0.958 |
24 |
46
|
2005 |
2019 |
Low density lipoprotein cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
483
|
1142
|
0.100 |
None |
1.000 |
8 |
5
|
2012 |
2019 |
Serum total cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
486
|
1243
|
0.100 |
None |
1.000 |
7 |
7
|
2012 |
2019 |
Tonometry
|
phenotype |
|
Diagnostic Procedure
|
206
|
573
|
0.100 |
None |
1.000 |
6 |
5
|
2014 |
2018 |
von Willebrand's factor (lab test)
|
phenotype |
|
Laboratory Procedure
|
55
|
427
|
0.100 |
None |
1.000 |
6 |
59
|
2010 |
2019 |
Alkaline phosphatase measurement
|
phenotype |
|
Laboratory Procedure
|
42
|
79
|
0.100 |
None |
1.000 |
4 |
5
|
2008 |
2018 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.040 |
None |
1.000 |
4 |
|
2004 |
2019 |
Corpuscular Hemoglobin Concentration Mean
|
phenotype |
|
Laboratory or Test Result
|
401
|
4389
|
0.100 |
None |
1.000 |
4 |
20
|
2010 |
2018 |
Activated Partial Thromboplastin Time measurement
|
phenotype |
|
Laboratory Procedure
|
17
|
44
|
0.100 |
None |
1.000 |
3 |
3
|
2012 |
2018 |
Red cell distribution width determination
|
phenotype |
|
Laboratory Procedure
|
593
|
988
|
0.100 |
None |
1.000 |
3 |
4
|
2016 |
2019 |
Hemoglobin measurement
|
phenotype |
|
Laboratory Procedure
|
131
|
224
|
0.100 |
None |
1.000 |
3 |
4
|
2010 |
2018 |
Mean Corpuscular Volume (result)
|
phenotype |
|
Laboratory or Test Result
|
269
|
549
|
0.100 |
None |
1.000 |
3 |
4
|
2016 |
2018 |
Finding of Mean Corpuscular Hemoglobin
|
phenotype |
|
Finding
|
653
|
1206
|
0.100 |
None |
1.000 |
3 |
3
|
2016 |
2019 |
RDW - Red blood cell distribution width result
|
phenotype |
|
Laboratory or Test Result
|
593
|
988
|
0.100 |
None |
1.000 |
3 |
4
|
2016 |
2019 |
Blood Protein Measurement
|
phenotype |
|
Laboratory Procedure
|
1156
|
2575
|
0.100 |
None |
1.000 |
3 |
22
|
2018 |
2019 |
Coughing
|
phenotype |
Pathological Conditions, Signs and Symptoms; Respiratory Tract Diseases
|
Sign or Symptom
|
235
|
16
|
0.020 |
None |
1.000 |
2 |
|
2011 |
2014 |
Red Blood Cell Count measurement
|
phenotype |
|
Laboratory Procedure
|
717
|
1599
|
0.100 |
None |
1.000 |
2 |
3
|
2018 |
2019 |